Annual report
7733.TEDINET S100YDN3
Period2025-04-01 → 2026-03-31
Filed2026-06-18
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.01T | 2025-04-01 → 2026-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥997.3bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥925.8bn | 2023-04-01 → 2024-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥881.9bn | 2022-04-01 → 2023-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥750.1bn | 2021-04-01 → 2022-03-31v | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥97.1bn | 2025-04-01 → 2026-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥162.5bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥94.0bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥159.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥43.6bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥182.3bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥141.7bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥68.2bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥117.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥242.6bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥143.4bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥115.7bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥68.2bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥117.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.54T | at 2026-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.43T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.53T | at 2024-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.51T | at 2023-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.36T | at 2022-03-31v | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥725.1bn | at 2026-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥681.5bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥812.0bn | at 2026-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥751.7bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥757.2bn | at 2024-03-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥812.0bn | at 2026-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥751.7bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥757.2bn | at 2024-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥640.1bn | at 2023-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥510.2bn | at 2022-03-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥188.0bn | at 2026-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥252.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥340.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥205.5bn | at 2023-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥302.6bn | at 2022-03-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥100.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥190.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥42.4bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥98.5bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥169.7bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥87.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥65.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥360.0bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥58.4bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥71.0bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥87.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥211.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥276.0bn | 2023-04-01 → 2024-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥143.2bn | 2022-04-01 → 2023-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥40.7bn | 2021-04-01 → 2022-03-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥61.32 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥102.99 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥199.91 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥113.22 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥90.22 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥61.2 | 2025-04-01 → 2026-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥102.8 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥199.44 | 2023-04-01 → 2024-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥113.08 | 2022-04-01 → 2023-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥90.17 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥737.48 | at 2026-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥666.54 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥649.59 | at 2024-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥510.62 | at 2023-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥400.75 | at 2022-03-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 52.8% | at 2026-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 52.4% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.4% | at 2024-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 42.4% | at 2023-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.6% | at 2022-03-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 8.7% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 15.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 34.7% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 24.9% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 25.6% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 28,138 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 29,297 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 28,838 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 32,805 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 31,557 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥407.0bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥389.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥379.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥380.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥378.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥30.2bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥12.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥77.2bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥69.5bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥135.1bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥152.3bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥57.2bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥100.7bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥70.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥86.1bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥61.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥293.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥130.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥84.8bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥890.6bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥913.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥954.9bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥973.6bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥900.9bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥417.6bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥455.8bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥473.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥457.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥512.9bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥418.3bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥357.2bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥41.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥112.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥77.45 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.89 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.97 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.88 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.13 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥77.3 | 2025-04-01 → 2026-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥53.79 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥241.41 | 2023-04-01 → 2024-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥102.76 | 2022-04-01 → 2023-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥66.1 | 2021-04-01 → 2022-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥429.41 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥405.22 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥439.81 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥333.48 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥280.3 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 53.1% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.7% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.9% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.5% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 63.1% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.6% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.0% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,114,486,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,139,116,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,215,147,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,266,179,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,299,294,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,469 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 2,494 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,834 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 2,727 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 3,478 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 0 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2026-03-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2026-03-31 | −¥499m |
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥895m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥245.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥23.8bn |
| Endoscopicreportable segment | employees | at 2026-03-31 | 17938 pure |
| Gastrointestinal Solutionsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥61.9bn |
| Gastrointestinal Solutionsreportable segment | segment assets | at 2026-03-31 | ¥735.1bn |
| Gastrointestinal Solutionsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥136.4bn |
| Surgical And Interventional Solutionsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥29.5bn |
| Surgical And Interventional Solutionsreportable segment | segment assets | at 2026-03-31 | ¥555.2bn |
| Surgical And Interventional Solutionsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥15.0bn |
| Surgical Interventionreportable segment | employees | at 2026-03-31 | 6856 pure |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥91.3bn |
| —segment total | segment assets | at 2026-03-31 | ¥1.29T |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥121.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥474m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥324.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥23.8bn |
| Gastrointestinal Solutionsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥55.1bn |
| Gastrointestinal Solutionsreportable segment | segment assets | at 2025-03-31 | ¥604.3bn |
| Gastrointestinal Solutionsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥171.4bn |
| Surgical And Interventional Solutionsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥28.6bn |
| Surgical And Interventional Solutionsreportable segment | segment assets | at 2025-03-31 | ¥500.1bn |
| Surgical And Interventional Solutionsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥15.3bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥83.7bn |
| —segment total | segment assets | at 2025-03-31 | ¥1.10T |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥186.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 0 pure |
| Endoscopicreportable segment | employees | at 2026-03-31 | 1259 pure |
| Surgical Interventionreportable segment | employees | at 2026-03-31 | 515 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,964
| Item | Context | Value | Unit |
|---|---|---|---|
| Total transactions with owners IFRS | CurrentYearDuration | -70144000000 | JPY |
| Equity IFRS | CurrentYearInstant_ShareCapitalIFRSMember | 124643000000 | JPY |
| Equity IFRS | CurrentYearInstant_CapitalSurplusIFRSMember | 93101000000 | JPY |
| Equity IFRS | CurrentYearInstant_TreasurySharesIFRSMember | -26631000000 | JPY |
| Equity IFRS | CurrentYearInstant_OtherComponentsOfEquityIFRSMember | 198596000000 | JPY |
| Equity IFRS | CurrentYearInstant_RetainedEarningsIFRSMember | 422331000000 | JPY |
| Equity IFRS | CurrentYearInstant_EquityAttributableToOwnersOfParentIFRSMember | 812040000000 | JPY |
| Equity IFRS | CurrentYearInstant | 812040000000 | JPY |
| Profit loss before tax IFRS | Prior1YearDuration | 159070000000 | JPY |
| Profit loss before tax IFRS | CurrentYearDuration | 93994000000 | JPY |
| Profit loss before tax from discontinued operations IFRS | Prior1YearDuration | 61000000 | JPY |
| Profit loss before tax from discontinued operations IFRS | CurrentYearDuration | － | JPY |
| Depreciation and amortization ope cf IFRS | Prior1YearDuration | 66456000000 | JPY |
| Depreciation and amortization ope cf IFRS | CurrentYearDuration | 67216000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | Prior1YearDuration | 3636000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | CurrentYearDuration | 12085000000 | JPY |
| Interest and dividend income ope cf IFRS | Prior1YearDuration | -3308000000 | JPY |
| Interest and dividend income ope cf IFRS | CurrentYearDuration | -2522000000 | JPY |
| Interest expenses ope cf IFRS | Prior1YearDuration | 4628000000 | JPY |
| Interest expenses ope cf IFRS | CurrentYearDuration | 4816000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | Prior1YearDuration | -466000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | CurrentYearDuration | 3700000000 | JPY |
| Decrease increase in trade and other receivables ope cf IFRS | Prior1YearDuration | -27725000000 | JPY |
| Decrease increase in trade and other receivables ope cf IFRS | CurrentYearDuration | -30460000000 | JPY |
| Decrease increase in inventories ope cf IFRS | Prior1YearDuration | -3410000000 | JPY |
| Decrease increase in inventories ope cf IFRS | CurrentYearDuration | -10666000000 | JPY |
| Increase decrease in trade and other payables ope cf IFRS | Prior1YearDuration | -1926000000 | JPY |
| Increase decrease in trade and other payables ope cf IFRS | CurrentYearDuration | 18521000000 | JPY |
| Increase decrease in retirement benefit liability ope cf IFRS | Prior1YearDuration | 1408000000 | JPY |
| Increase decrease in retirement benefit liability ope cf IFRS | CurrentYearDuration | -498000000 | JPY |
| Decrease increase in retirement benefit asset ope cf IFRS | Prior1YearDuration | -1197000000 | JPY |
| Decrease increase in retirement benefit asset ope cf IFRS | CurrentYearDuration | -735000000 | JPY |
| Increase decrease in provisions ope cf IFRS | Prior1YearDuration | -15225000000 | JPY |
| Increase decrease in provisions ope cf IFRS | CurrentYearDuration | 6068000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YearDuration | 6338000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYearDuration | 2966000000 | JPY |
| Subtotal ope cf IFRS | Prior1YearDuration | 188340000000 | JPY |
| Subtotal ope cf IFRS | CurrentYearDuration | 164485000000 | JPY |
| Interest received ope cf IFRS | Prior1YearDuration | 3296000000 | JPY |
| Interest received ope cf IFRS | CurrentYearDuration | 2509000000 | JPY |
| Dividends received ope cf IFRS | Prior1YearDuration | 12000000 | JPY |
| Dividends received ope cf IFRS | CurrentYearDuration | 13000000 | JPY |
| Interest paid ope cf IFRS | Prior1YearDuration | -4194000000 | JPY |
| Interest paid ope cf IFRS | CurrentYearDuration | -4048000000 | JPY |
| Income taxes refund paid ope cf IFRS | Prior1YearDuration | 3009000000 | JPY |
| Income taxes refund paid ope cf IFRS | CurrentYearDuration | -62374000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YearDuration | 190463000000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYearDuration | 100585000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | Prior1YearDuration | -46001000000 | JPY |
| Purchase of property plant and equipment inv cf IFRS | CurrentYearDuration | -55558000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |